newsLilly will acquire Akouos to accelerate hearing loss therapies19 October 2022 | By Catherine Eckford (European Pharmaceutical Review)Eli Lilly and Company’s $610 million acquisition of Akouos will fast-track gene therapies that restore, improve and preserve hearing for patients worldwide.